S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RTW Investments/Q3 2021

RTW Investments

Periodo: Q3 2021 Β· Depositato: 2021-11-15
Vedi su SEC EDGAR β†—
AUM
$6.63B
Valore totale del portafoglio
Posizioni
120
Titoli dichiarati
Prima Posizione
RCKT
7.1% $469.6M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-11-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
RCKTROCKET PHARMACEUTICALS INC$469.6M7.08%$29.89$3.84-87.2%
7.1%
SPYSPDR S&P 500 ETF TR$374.8M5.65%$402.37$744.78+85.1%
5.7%
ALNYALNYLAM PHARMACEUTICALS INC$317.8M4.79%$188.81$312.78+65.7%
4.8%
MRTXMIRATI THERAPEUTICS INC$264.0M3.98%β€”β€”
4.0%
TMOTHERMO FISHER SCIENTIFIC INC$237.7M3.58%$563.66$523.44-7.1%
3.6%
MASIMASIMO CORP$225.4M3.40%$270.71β€”
3.4%
VCELVERICEL CORP$220.5M3.32%$48.80$46.98-3.7%
3.3%
CLDXCELLDEX THERAPEUTICS INC NEW$211.0M3.18%$53.99$38.37-28.9%
3.2%
NTRANATERA INC$207.5M3.13%$111.44$279.32+150.7%
3.1%
PTCTPTC THERAPEUTICS INC$197.0M2.97%$37.21$83.31+123.9%
3.0%
ILMNILLUMINA INC$195.8M2.95%$394.56$188.68-52.2%
3.0%
ESTAESTABLISHMENT LABS HLDGS INC$166.0M2.50%$71.58$89.25+24.7%
2.5%
DRNADICERNA PHARMACEUTICALS INC$152.9M2.31%β€”β€”
2.3%
TNDMTANDEM DIABETES CARE INC$138.6M2.09%$119.38$15.32-87.2%
2.1%
GMEDGLOBUS MED INC$128.0M1.93%$76.62$80.12+4.6%
1.9%
AXNXAXONICS INC$126.5M1.91%β€”β€”
1.9%
RNAMAVIDITY BIOSCIENCES INC$118.1M1.78%β€”β€”
1.8%
GHGUARDANT HEALTH INC$115.7M1.74%$125.01$167.98+34.4%
1.7%
CCCCC4 THERAPEUTICS INC$111.5M1.68%$44.68$4.30-90.4%
1.7%
ISEEIVERIC BIO INC$109.2M1.65%β€”β€”
1.6%
FULCFULCRUM THERAPEUTICS INC$108.8M1.64%$28.21$3.84-86.4%
1.6%
TXG10X GENOMICS INC$106.9M1.61%$145.58$39.01-73.2%
1.6%
PENPENUMBRA INC$102.7M1.55%$266.50$318.57+19.5%
1.6%
DMTKQDERMTECH INC$100.1M1.51%β€”β€”
1.5%
STOKSTOKE THERAPEUTICS INC$92.7M1.40%$25.44$32.70+28.5%
1.4%
IDYAIDEAYA BIOSCIENCES INC$83.3M1.26%$25.49$37.65+47.7%
1.3%
MGNXMACROGENICS INC$83.3M1.26%$20.94$4.71-77.5%
1.3%
RXDXPROMETHEUS BIOSCIENCES INC$77.4M1.17%β€”β€”
1.2%
RGNXREGENXBIO INC$77.4M1.17%$41.92$13.28-68.3%
1.2%
CYTKCYTOKINETICS INC$71.5M1.08%$35.74$86.49+142.0%
1.1%

AttivitΓ  Trimestre su Trimestre

Q3 2021 vs. Q2 2021

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
TMOTHERMO FISHER SCIENTIFIC INC$237.7M-7.1%
PENPENUMBRA INC$102.7M+19.5%
TNYATENAYA THERAPEUTICS INC$48.6M
SGHTSIGHT SCIENCES INC$29.1M
WHWKAADI BIOSCIENCES INC$21.3M
RCORRENOVACOR INC$19.3M
URGNUROGEN PHARMA LTD$14.4M
OSURORASURE TECHNOLOGIES INC$13.3M

Posizioni Chiuse (8)

TickerEmittenteNozionale
QDELXXXXQUIDEL CORP$112.6M
TRILLIUM THERAPEUTICS INC$20.3M
CHAQCHARDAN HEALTHCR ACQSTN 2 CO$8.3M
BCTGBCTG ACQUISITION CORP$6.8M
ITMRITAMAR MED LTD$6.3M
RACATHERAPEUTICS ACQUISITION COR$5.0M
CHAQUCHARDAN HEALTHCR ACQSTN 2 CO$3.6M
PSNLPERSONALIS INC$3.2M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ARGXARGENX SE$32.8M+341.9%
CUTRQCUTERA INC$23.3M+74.5%
PMVPPMV PHARMACEUTICALS INC$7.6M+67.3%
MGNXMACROGENICS INC$14.8M+56.1%-77.5%
IMUXIMMUNIC INC$0.8M+48.9%
ITOSITEOS THERAPEUTICS INC$19.5M+37.1%
CERECEREVEL THERAPEUTICS HLDNG I$6.9M+33.3%
OMOUTSET MED INC$7.4M+21.4%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
MDXGMIMEDX GROUP INC$-32.0M-89.0%
PTGXPROTAGONIST THERAPEUTICS INC$-126.3M-50.0%
CSTLCASTLE BIOSCIENCES INC$-18.8M-25.0%
ABUSARBUTUS BIOPHARMA CORP$2.2M-20.8%
AGENAGENUS INC$-15.2M-20.7%
EPIXESSA PHARMA INC$-66.2M-13.6%
SPYSPDR S&P 500 ETF TR$-51.7M-12.3%+85.1%
GTHGENETRON HLDGS LTD$-13.5M-8.0%
← Torna agli Hedge Fund